




















This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 















































































































mesenchymal" stem"cell" (MSC)" secretome" is" an"avenue"being" researched" in"
regenerative" medicine" which" could" potentially" ameliorate" the" condition."













were" compared" to" untreated" diabetic" mice" and" a" nonZdiabetic" control." A"






This" thesis" demonstrates" that" the"MSCZCM" ameliorates" falls" in" viability" of"
BRINZbd11"and"TC6"cell" lines"in"the"presence"of"proZinflammatory"cytokines"
implicated" in" the" pathogenesis" of" diabetes" in" an" in# vitro" model." It" also"




Thus,"MSCZCM"appears" to"be"a"potential" therapeutic" tool" for"use" in" type"1"
diabetes." Further" research" needs" to" be" conducted" to" determine" the"















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































use! of! exogenous! insulin! is! not! a! cure,! and! it! poorly! mirrors! the! normal!
physiological! response! to! changes! in! blood! glucose.! Poor! glucose! control!
increases!the!risk!of!complications!including!microvascular!complications!such!
as! diabetic! neuropathy! and! retinopathy! and! macrovascular! complications!
such! as! stroke! and! ischaemic! heart! disease.
(3)
The! Diabetes! Control! and!
















The! idea! of! transplanting! islets! to! obtain! a! physiological! insulin! response!
predates!the!advent!of! insulin!therapies!for!type!1!diabetes.!Early!attempts!




! The! child’s! condition! improved! initially,! but! the! graft!
subsequently!failed,!most!likely!due!to!rejection!and!ischaemia!at!the!poorly!
vascularised! site.! In! the! 1960s! islet! isolation! and! transplantation! was!
pioneered! by! Lay! et# al.,! who! successfully! demonstrated! restoration! of!











patients!who!received! islet! transplantations! from!cadaveric!donors!became!




























Figure#1.1# :#Depiction#of# the# islet# transplantation#process.# Islets#are# isolated#from#the#donor#and#










recipient)! was! one! of! the! key! modifications! of! the! islet! transplantation!







partly! due! to! insufficient! transfusion! and! subsequent!engraftment! of! islets!
















to! prevent! graft! rejection,! consisting! initially! of! induction!with! Daclizumab!
followed! by! maintenance! therapy! with! Tacrolimus! and! Sirolimus.
! (8)!
! As!






















need! for! supplemental! transplant! and! six! demonstrated! continued! islet!





The! initial! results! of! the! Edmonton! Protocol! sparked! renewed! interest! in!
research! into! the! transplantation! of! islets,! with! many! groups! trying! to!
reproduce! the! results.! In! 2006! an! international! trial! involving! nine!
international!centres!(six!in!North!America!and!three!in!Europe)!was!carried!
out! to! determine! if! the! results! of! the! Edmonton! Protocol! were!
reproducible.
(10)

















the! subjects! reached! the! primary! endpoint,! which! was! defined! as! insulin!










or! within! 2! months! of! transplantation! (early! loss! of! graft).
(10)
! The! study!
























! Improvements! in! islet! isolation,! peritransplant! handling! to! reduce!
cold! ischaemia! loss! of! islets,! as! well! as! improvements! in! the!
immunosuppression! regimen! to! reduce! toxicity! to! transplanted! islets!





Although! the! results!are!promising,! there!are!currently!many! limitations! to!






















highly! susceptible! to! ischaemia,! although! methods! of! prolonging! the! cold!










Due! to! the! limited! supply! of! islets,! criteria! for! inclusion! in! the! trials! are!
relatively!stringent.!Ideal!candidates!for!trials!as!described!by!!Srinivan!et#al.!
are! insulinMsensitive! individuals! with! type! 1! diabetes! who! have! poor!


















include!portal! vein! thrombosis,!which!can!have!a! fatal!outcome,!as!well!as!
portal! hypertention.
(18)
! Islets! tend! to! cause! blood! to! clot,! affecting! their!












of! fields! including! endocrinologists,! transplant! surgeons! and! interventional!
radiologists.
(20)
! Psychologists! are! also! involved!who! determine! the! patients!






transplanted!grafts.! Ironically,! the! immunosuppressants!used! in! these!trials!
were! toxic! to! the! transplanted! grafts! and! impaired! their! function.
(21)!
Glucocorticoids!were! recognised! to! be! cytotoxic! to! transplanted! islets! and!



















































Human! embryonic! stem! cells! (hESCs)! are! pluripotent! stem! cells! that! are!
capable! of! differentiating! into! all! three! germ! layers! of! embryonic!
development! (ectoderm,!mesoderm!and! endoderm).
! (24)
! These! cells! exhibit!
characteristics!of!pluripotency,!including!forming!tumours!containing!tissue!of!

























human! embryonic! stem! cells! followed! in! 1998.
(29)
! The! ability! of! hESCs! to!
differentiate!into!many!different!cell!types!has!been!extensively!researched!
for! use! in! many! diseases,! including! type! 1! diabetes.! The! first! study! to!

















cells! for! hESC! cultures! include!mouse! embryonic! fibroblasts.
(32)
! These! cells!
support! hESCs! attachment! through! secretion! of! extracellular! matrix! and!
expression!of!adhesion!molecules,!!promote!growth!and!survival!of!ESCs!and!










from! ESCs! starts! with! the! production! of! definitive! endoderm! via! the!
introduction! of! factors! such! as! Activin! A,! WNT3A! and! bone! morphogenic!
proteins! into! hESCs.
(35)
























































the! capacity! to! generate! beta! cells! from! the! patient’s! own! cells,! thus!
eliminating!the!risk!of!graft!rejection.!In!theory,!any!cell!can!be!harvested!and!




! It! is!also!not!subject!to!the!same!ethical! issues!
























compromised!mice,!as!well!as! the!capacity! to!be! incorporated! into! the!cell!









cells! for! transplantation.! Numerous! studies! have! been! published!














into! the! liver! of! a! murine! model! of! diabetes! resulted! in! normalisation! of!




Despite! promising! results,! these! cells! currently! present! a! number! of!






into! the! host! genome.! This! also! increases! the! risk! of! tumorgenicity.
(45)
!







the! use! of! a! nonMintegrating! Sendai! viral! vector! that! avoids! integration! of!












achieving!pluripotency!depending!on! the!method!of! gene! transfer! and! the!
host! cells! used.
(42)






































when! they! interact! with! MSCs.
(51)
! Peripheral! control! of! TMcell! activation! is!
described!in!more!detail!in!Section!1.2.3.!They!can!readily!be!obtained!from!
donors,!grown,!and!expanded!in!culture.!They!can!maintain!their!pluripotency!
even! after! prolonged! periods! in! culture.
(52)!
These! factors! make! MSCs! an!
attractive! option! for! cellular! therapy.! The! International! Society! for! Cellular!
Therapy! has! offered! criteria! for! identifying!MSCs! in! culture.! These! are! (1)!
expression! of! certain! surface! markers! (CD73,! CD90,! and! CD105)! and! the!
absence!of!other!surface!markers!(CD34,!CD45,!CD14,!CD11B,!CD19!and!HLA!























! IPCs! derived! using! this!method! could! normalise! blood! glucose! in!
streptozocin! (STZ)! induced!murine!models! of! diabetes! for! a! period!of! nine!
weeks.
(54)




Another! avenue! being! explored! is! the! systemic! administration! of!MSCs! to!






regenerative! properties! of! transplanted! MSCs.! Bone! marrowMderived!
mesenchymal!stem!cells!(BMMMSCs)!have!been!shown!to!express!chemokine!
receptors!including!CXCR4!and!CX3CR1!that!respond!to!chemokines!such!as!













The! mechanisms! behind! the! regenerative! effects! demonstrated! by!
transplanted!MSCs!that!engraft!in!the!pancreas!is!an!area!of!debate.!A!study!
by!Li!et#al.! showed!that! the!microenvironment!of! the! injured!pancreas!can!
induce!the!expression!of!nestin,!NGN3!and!PDX1,!which!are!genes!specific!for!
beta! cell! development! and! insulin! production.
(56)
! This! suggests! that! MSCs!
could!transdifferentiate!into!insulinMproducing!cells!at!the!site!of!the!pancreas.!
MSCs! could! also! provide! trophic! support! to! viable! beta! cells! within! the!







One! issue!with! the! systemic!administration!of!MSCs! is! the! ‘pulmonary! first!
pass! effect’.!MSCs! tend! to! become! trapped! in! the!microvasculature! of! the!



























gaining! interest! in! recent! years,! as! it! provides! several! advantages! over!
conventional! stem!cell! therapy.!The!MSC!secretome!allows!the! therapeutic!
effects!of!MSCs!to!be!utilised!without!the!need!for! transplanting!cells.!This!
eliminates! the! risks! of! the! surgery! needed! for! engraftment! and! the! risk! of!
immune! incompatibility,! and! reduces! the! risk! of! transmission! of! infections!
through! grafted! cells.! Systemic! administration! of! stem! cells! does! however!





Proteomic! assays! of! media! conditioned! by!MSCs! have! been! performed! to!








range! of! soluble! factors! that! include! angiogenic! factors! (e.g.! VEGF,!
angiogenin),!growth!and!trophic!factors!(e.g.!BDNF,!EGF,!PIGF),!chemokines!
(e.g.! CCL1,! CXCL2),! antiMinflammatory! cytokines! (e.g.! ILM10,! ILM13)! and!
haematopoietic! cytokines,! among! others.
(63)
! These! factors! provide! the!
therapeutic! properties! associated! with! the!MSC! secretome.! These! include!
promoting! angiogenesis! via! factors! such! as! VEGF! and! angiogenin,! which!





































Based!on! their! structure! and!origin,! EVs! can! be! classified! into!
exomes! and! microvesicles.! Exomes! are! derived! from! the! endosomal!
compartment!and!microvesicles!are!produced!from!direct!budding!from!the!
plasma! membrane.! They! contain! proteins,! polysaccharides,! mRNA! and!
microRNA.
(67)
! EVs! allow! for! the! horizontal! transfer! of! mRNA! and! miRNA!
between!MSCs! and! target! cells! allowing! for! alterations! in! gene! expression!
within! these! cells.
(70)
! For! example,! MSCMderived! EVs! have! been! shown! to!




They!have!also!been! shown! to! induce!genes! for! angiogenesis! in!models!of!














1.1.6!Immunomodulatory! and! Anti9Apoptotic! Properties! of! the!
MSC!Secretome!
Autoimmune! diabetes! is! classically! described! as! a! TH1Mmediated! response!






a! TH1! phenotype! is! one! of! the!major!mechanisms! behind! the! therapeutic!
effect!of!MSCs!seen!in!murine!models!of!diabetes.!
!
MSCs!are!able! to!modulate! the!responses!of!T–cells,!a!key!mediator! in! the!





catalyses! the! conversion! of! tryptophan! to! kynurenine.! This! leads! to! the!
depletion! of! tryptophan! and! a! buildMup! of! its! metabolites! locally,! which!
inhibits! TMcell! proliferation.
(65,74,75)
! Direct! cellMtoMcell! contact! between!MSCs!

















MSCs! could! mediate! a! shift! from! a! TH1! to! a! TH2! response! by!







increases! the! expression! of! ILM10! by! macrophages! and! inhibits! the!
proliferation! of! TMcells.
(76,50)
! TSG6! can! decrease! the! production! of! proM







effects! on! a!wide! range! of! other! immune! cells.! They! have! been! shown! to!








proliferation! and! cytotoxicity! as! well! as! inhibit! B! cell! proliferation! and!
maturation.
(65)






















































! The! epithelium! of! the! thymus! develops!








marrow! during! its! development,! including! thymocytes,! dendritic! cells! and!
macrophages.
(82,83)























































The! expression! of! specific! adhesion! molecules! can! be! used! to! stage! the!
development!of!doubleMnegative!thymocytes!in!humans!and!mice!(Figure!1.4).!!
#
Using! mice! as! an! example,! the! expression! of! CD44,! CD25! and! cMkit! vary!
depending!on!the!stage!of!development!(Figure!1.4).!Initially,!doubleMnegative!
thymocytes!express!cMkit!and!CD44!but!not!CD25.!This!is!known!as!the!doubleM
negative! 1! (DN1)! stage.
(84,85,87)






gene! encoding! the! TCRMbeta! chain! survive.
(84,85,87)








! The! beta! chains! pair! with! surrogate! preMTCR! alpha! chains!





















to! MHC/peptide! complexes! are! selected! to! receive! “survival! signals”! that!
allow! them! to!develop! further! into! single!positive! thymocytes.!
(89,90)
! In! this!






chemokine! CCR7! to! undergo! negative! selection.
(89)!




mTECs! ! express! a! wide! range! of! self! antigens! including! ! Tissue! Restricted!








































above! can! lead! to! autoimmunity.! The! susceptibility! loci! are! gene! regions!
associated!with!a!specific!disease.!In!type!1!diabetes,!association!studies!and!








in! defects! in! peptide! presentation! and! subsequent! failure! of! negative!
selection! in! the! thymus.
(94M100)
! An! example! of! gene! variations! affecting! the!
expression! of! peptides! is! variations! in! the! AIRE! gene.! ! The! AIRE! gene!
contributes! to! the! expression! of! tissueMspecific! antigens! by! mTECs! in! the!
medulla.
(94)




























implicated! in! defective! thymic! education! of! TMcells.
(98)






















the! risk! of! TMcells! autoMreactive! against! insulin! evading! negative!
selection.
(99,100)
! Class! III! alleles! (140M210! repetitions)! conversely! increase!




is! associated! with! an! average! threefold! increase! of! insulin! in! the! thymus!










thymus! and! induced! TMregs! (iTregs)! that! form! in! the! periphery.
(102)
! FOXP3!
expressing! CD4+! TMcells! generated! in! the! thymus! (nTregs)! are! well!
characterised! as! regulatory! TMcells.! Mutations! in! FOXP3! result! in!
immunodysregulation! polyendocrinopathy! enteropathy! XMlinked! syndrome!
(IPEX)! that! leads! to!dysfunction!of! regulatory!TMcells!and!autoimmunity.
(103)
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!Within! the! thymus,! the!mechanisms! that! control!
whether! a! thymocyte!undergoes! clonal! deletion! to! form!effector! TMcells! or!
clonal! diversion! to! form! nTregs! is! very! much! debated.! TCR! avidity! or! the!



























FOXP3! TMcells! are! important! in! the! pathogenesis! of! type! 1! diabetes.
(81,108)
!












Clonal!deletion!within! the! thymus! is!not!a!perfect!process!and! some!autoM
reactive!cells!survive!the!process!and!enter!the!periphery.!Mechanisms!exist!
in!the!periphery!to!prevent!the!activation!and!clonal!expansion!of!these!selfM
reactive! TMcells.! The! activation! of! TMcells! requires! the! TCR! signal,! which!
involves!the!binding!of!the!TCR!receptor!to!MHC!class!II/peptide!complexes!
on! antigenMpresenting! cells.! A! second! signal! involving! coMstimulatory!
















! Thus! the! balance! between! the! positive! signal!























1.2.4!Pro9Inflammatory! Cytokines! and! their! Role! in! Beta! Cell!
Dysfunction!
Autoimmune!diabetes! is! characterised!by!an! infiltration!of! the! islets! in! the!
pancreas! by! immune! cells! leading! to! inflammation! in! a! process! termed!
insulitis.
(113)
! Infiltrating! cells! secrete! a! range! of! proMinflammatory! cytokines!
into! the!microenvironment! of! the! islets.! These! cytokines,! ILM1β! and! TNFα,!
perpetuate! this! inflammatory! response! by! activating! immune! cells,!
upregulating! ICAMM1! on! the! vascular! endothelium! and! stimulating! the!








macrophages! and! antigenMpresenting! cells! to! the! inflamed! islets.
(114,115)
!
Pancreatic! beta! cells! have! also! been! shown! to! secrete! proMinflammatory!
cytokines! in! response! to! a! proMinflammatory! environment.
(116)
! This! positive!
feedback! mechanism! leads! to! progressive! destruction! of! beta! cells! and!
depletion! of! the! beta! cell!mass,! eventually! resulting! in! clinical! diabetes.! A!
number! of! these! cytokines! have! been! implicated! in! the! pathogenesis! of!





































































of! the! NFMκB! family! of! proteins! (Figure! 1.7).! This! interaction! results! in! the!














































Nitric!oxide!(NO)! is!a!compound!involved! in!many!biological!processes.! It! is!






! as!well! as!many! cellular! functions,! including! cell! division! and!
proliferation.
(130)
! Production! is! controlled! by! the! regulation! of! nitric! oxide!
synthase!(NOS).
(131)
! Its!role! in!cell!survival! is!complex.! It!has!been!shown!to!
have!an!antiM!or!proMapoptotic!signal!depending!on!the!concentration!of!NO!
and!the!cell!type!in!question.!NO!can!prevent!apoptosis!at!many!points!in!the!




! However! in! beta! cells! production! of! NO! after!



















of! reactive! oxygen! species! (ROS)! and! oxidative! stress.! ROS! damage! critical!
cellular! components.
(137)




















NO!has!also!been!shown! to! inactivate! the!mitochondrial!enzyme!aconitase!





This! results! in! the! depletion! of! NAD
+
! and! subsequent! depletion! of! ATP.!




PAR! which! stimulates! mitochondrial! release! of! AIF.
(141)
! NO! can! nitrosylate!











This! rapid! and! constantly! changing! protein! synthesis! leaves! beta! cells!















ER! transmembrane! receptors:! protein! kinase! RNAMlike! ER! kinase! (PERK),!




















conserved! binding! sites! for! the! zinc! finger! transcription! factor! Sp1.!
Downregulation! of! Sp1! via! NO! leads! to! downregulation! of! SERCA2b!
expression.
(136)!
Inactivation! and! downregulation! of! the! pump! leads! to!




















beta! cellMspecialised! functions.! A! number! of! genes! that! regulate! beta! cell!
functionality! have! been! shown! to! be! downregulated!on! exposure! to! these!
cytokines.! PDX1! is! a! gene! that! governs! the!embryonic! development!of! the!









a! potential! therapeutic! benefit! of! PDX1! gene! therapy! in! the! treatment! of!
autoimmune! diabetes.
(145)

















As! previously! discussed! the! channel! is! important! in! the!








role! on! many! cell! types.
(121)




















against! free! radicalMinduced! cytotoxicity! and! apoptosis.! Some!of! the! genes!
implicated! include! manganese! superoxide! dismutase! (MnSOD).! This! is! an!
essential! scavenger! enzyme! that! detoxifies! the! free! radical! superoxide,!
preventing! ROSMmediated! cellular! damage.
(148)
! Expression! of! this! protein! in!































causes!an! increase! in! the!expression!of!MnSOD!and!other! ‘defence!genes’.!
















cMJun!NH2Mterminal! kinase! (JNK),! extracellular! signalMregulated! kinase! (ERK)!
and! the! p38MMAPKs.
(153,154)
! MAPKKK! (MAP! kinase! kinase! kinase)! activate!
MAPKK! (MAP! kinase! kinase)! which! in! turn! activate!MAPK! that! goes! on! to!










































































The! importance!of! the!MAPK!pathway! in! the!pathogenesis!of! autoimmune!
diabetes! has! been! evaluated! via! the! use! of! inhibitors! of! p38! and!MEK1/2!
signalling!in!several!studies.!These!studies!have!shown!that!blocking!p38!and!
ERK! provided! protection! against! beta! cell! apoptosis.
(158,159,160,161)!
The!







in! beta! cell! apoptosis.! ERK! has! been! shown! potentially! to! augment! NFMκB!


























initially! identified! as! a! UVMresponse! protein! kinase! involved! in! the!
phosphorylation! of! cMJun! on! its! NMterminal! transactivation! domain!
ser60/ser73.! Evidence! of! its! proMapoptotic! role! came! from! studies! on!












Activation! of! JNK! by! exposure! to! proMinflammatory! cytokines! is! known! to!
induce! apoptosis! in! beta! cells.
(167,168,169)













has!been!shown!to!upregulate! the! transcription!of!a!number!of!genes! that!
induce! apoptosis! including! FASML,! TNFα! and! BAK.
(170,171)
! This! pathway! is!
implicated!in!the!regulation!of!apoptosis!in!several!cell!types,!including!cells!
in! the! central! nervous! system! in! which! blockage! leads! to! reduced!
apoptosis.
(170)
! ! The! expression! of! APM1! target! genes! on! exposure! to! proM
inflammatory! cytokines! may! play! a! crucial! role! in! triggering! beta! cell!
apoptosis.!Using!the!ATF3!transcription!factor!as!an!example,!transgenic!mice!
expressing! ATF3! developed! abnormal! islets.
(169)














has! also! been! shown! to! interact!with! proteins! implicated! in! the! apoptotic!
pathways.!These!proteins! include!the!BclM2!protein!family!which!consists!of!
proMapoptotic!members! (BAX/BAK)! that! form! the!mitochondrial! apoptosisM
induced! channel! (MAC)! on! the! mitochondrial! membrane,! leading! to! the!
release! of! cytochrome! c,! formation! of! the! apoptosome! and! subsequent!





initiation! of! the! intrinsic! pathway! of! apoptosis.
(171)
! Phosphorylation! of! Bim!
could!also!bind!and!neutralise!the!antiapoptotic!activity!of!BclM2!and!BclMxL.!
JNK! has! also! been! shown! to! phosphorylate! and! activate! the! p53! tumour!














Interleukin! 10! (ILM10)! is! a! cytokine! that! is! well! characterised! for! its! antiM
inflammatory!properties.
(173,174)








































the! cytoplasm.! ILM10R1! recruits! Janus!Kinase!1! (JAK!1)! and! ILM10R2! recruits!
Tyrosine! Kinase! 2! to! the! protein! complex.
(183)













residues! via! their! CMterminal! SH2! domain.
(185)










































inhibition! of! the! ILM6! receptor.
(192)
! These! are! but! a! few! of! the! AIR! factors!























Studies! have! shown! that! although! the! binding! of! ILM10! and! ILM6! to! their!
receptors!both!activate!STAT3,!ILM10!has!a!predominantly!antiMinflammatory!
effect! on! dendritic! cells! and! ILM6! elicits! a! predominately! proMinflammatory!
response.
(193)
! Indeed,! under! the! right! conditions,! both! ILM6! and! ILM10! are!













that! are! ‘primed’! to! express! predetermined! genes! upon! activation! of!
STAT3.
(174)
! The! genomic! targets! vary! between! cell! types! resulting! in! the!




As! previously! discussed,! autoimmune! diabetes! is! classically! described! as!
predominantly! TH1! or! cellMmediated! autoimmune! disease! where! the!
activation! of! cytotoxic! TMcells! and! the! expression! of! proMinflammatory!
cytokines! at! the! islets! of! Langerhans! leads! to! insulitis! and! the! progressive!
destruction! of! beta! cells.
(198)
! Although! a! TH2! response! is! implicated! in! the!
pathogenesis!of!Type!1!diabetes.
(198)
! ILM10!was! first!described! for! its! role! in!
TH1/TH2!crossMregulation.!!ILM10!produced!by!TH2!cells!directly!suppresses!the!











































cells! and! ILM10! production.
(204)!
ILM10Msecreting! TMregs! exert! most! of! their!




















chemotaxis! of! TH1Minduced! cells! to! the! pancreatic! islets.
(208)
! As! alluded! to!
earlier,! ILM10! is! able! to!block! the!expression!of!NFMκB,! thus!dampening! the!





The! promising! immunomodulatory! properties! of! ILM10! have! made! it! an!
attractive!option!for!the!treatment!of!TH1Mmediated!autoimmune!diseases.!
ILM10!has!previously!been!shown!to!be!effective!in!modulating!autoimmune!
conditions! such! as! inflammatory! bowel! disease,! where! systemic!
administration!of! ILM10!reduced!colonic! inflammation! in!murine!models.
(209)!
















the! progression! of! autoimmune!diabetes.
(210)


































Although! ILM10! is! conceptually! an! attractive! option! for! the! treatment! of!
autoimmune!diabetes,!it!is!clear!that!many!challenges!remain.!More!studies!













































































In! the! introduction,!we! determined! that! treating! type! 1! diabetes! presents!
many! challenges.! The! stem! cell! secretome!may!present! a! novel! and! viable!
method!of!treating!type!1!diabetes!in!the!future.!Determining!the!therapeutic!
potential!of! the!MSC!secretome! in!ameliorating!the!pathogenesis!of! type!1!
diabetes! as! well! as! characterising! the! components! of! the! secretome! that!

















•! Culture! human! bone! marrow! derived! MSCs,! characterise! the! cells!





















•! Establish! a! murine! model! of! type! 1! diabetes! via! multiple! low! dose!
Intraperitoneal!injections!of!streptozocin!(STZ).!












•! Characterise! the! presence! of! the! ILM10! receptor! on! beta! cell! lines!
through!Electrophoresis!







































































































































































































































































































































Ethical! statement:! Bone!Marrow!Mononuclear! cells! were! purchased! from!








The! TC6! cell! line!was! initially! cultured! in! low! glucose! Dulbecco’s!Modified!
Eagles!Medium!(DMEM)!with!1g/L!glucose!due!to!the!potential!sensitivity!of!
TC6!cells!to!higher!concentrations!of!glucose.(220)!This!was!supplemented!with!










DMEM! supplemented! with! 15%! heat@inactivated! foetal! bovine! serum! was!
found! to! provide! good! growing! conditions! for! these! cells.! This! optimised!



















BRIN@bd11! cell! line! is! a!hybrid! cell! line!produced!via! the!electrofusion!of! a!
primary!culture!of!NEDH!rat!pancreatic!cells!with!RINm5F,!which!is!a!cell!line!






is! derived! from! insulinoma! cells! obtained! from! transgenic! mice.(222)! These!
mice! carry! the! pseudogene! construct! composed! of! the! SV40! early! region!
















Stoke@on@Trent,! UK.! Cell! culture!methods! were! performed! in! laminar! flow!






in! cell! culture.! Cryovials! containing! the! cells! were! removed! from! liquid!
nitrogen.!The!cryovials!were!heated!in!a!37oC!Grant!JB!Nova!(Grant,!Royston,!
UK)!water!bath! to! facilitate! rapid!defrosting!of! the!cells.!The!defrosted!cell!
suspension!in!each!cryovial!was!added!to!a!15ml!centrifuge!tube!containing!
4ml! of! medium! and!mixed! well.! The! cell! suspension! was! centrifuged! in! a!
HeraeusTM! MegafugeTM! 8! Small! Benchtop! Centrifuge! (Thermo! Scientific! ,!
Osterode!am!Harz,!Germany)!at!900rpm!for!5!minutes.!The!supernatant!was!































UK)! at! 37oC! for! 4@5!minutes! to! allow! cells! to! detach! from! the! flasks.! After!
incubation,!the!cells!were!viewed!under!a!Olympus!CKX41!(Olympus,!Tokyo,!






was!used! to!wash! the! flask! several! times,! to!maximise! the!number!of! cells!
retrieved.!The!suspension!of!cells!was!aspirated!from!the!flasks!and!added!to!
a!50ml! centrifuge! tube!and!centrifuged! in!a!HeraeusTM!MegafugeTM!8!Small!




medium.! At! this! point! the! cells! could! be! counted! to! be! used! in! other!










































fibronectin! in!PBS!and! incubated! in!a!MCU@18AC@PE! Incusafe!CO2!Incubator!
(Panasonic,! Leicester,! UK)! at! 37oC! for! an! hour.! After! this! period,! the!
fibronectin!solution!was!removed!and!20ml!of!complete!MSC!medium!added!







detailed! in! Section! 2.2.4.! The! thawed!mononuclear! cells!were! seeded! at! a!
density!of!105!cells/cm2!in!the!fibronectin!pre@treated!flasks.!The!cells!were!









incubated! in! a!MCU@18AC@PE! Incusafe! CO2! Incubator! (Panasonic,! Leicester,!
UK)! at! 37oC.!MSCs! generally! detach! after! 3@4!minutes! of! exposure! to! 10%!
trypsin,!while!other!mononuclear! cells! take!much! longer! (~10@15!minutes).!









a!15ml! centrifuge! tube!and!centrifuged! in!a!HeraeusTM!MegafugeTM!8!Small!










Superfluous! cells! were! frozen! in! liquid! nitrogen! for! future! use.!
Cryopreservative!was!prepared!consisting!of!10%!dimethyl!sulfoxide!(DMSO).!
20%!FBS!and!70%!culture!medium.!Cells! in!suspension!to!be!cryopreserved!
were! counted! as! described! in! Section! 2.2.6.! The! cells! were! centrifuged! at!
900rpm! in! a!HeraeusTM!MegafugeTM!8! Small! Benchtop! ! Centrifuge! (Thermo!
Scientific! ,!Osterode!am!Harz,!Germany)for!5!minutes!and! the! supernatant!








added! to! each! 2.5ml! cryotube.! The! cryovials! were! stored! in! a! Mr! Frosty!
cryopreserving! container! (Thermo! Scientific,! Windsford! ,! UK)! in! a! MDF@








as! detailed! in! Section! 2.2.8.! MSC@CM! was! produced! using! cells! in! early!
passages!(P2@P3)!before!signs!of!cellular!senescence!were!seen.!(e.g.!cellular!
enlargement,! increase! in!cellular!vacuoles/debris).! (224)!Senescent!cells!have!
been!shown!to!mount!a!pro@inflammatory!response!by!activation!of!a!process!
known! as! the! senescence@associated! secretory! phenotype! (SASP).! This!














When! MSCs! were! between! 70@80%! confluence,! the! growth! medium! was!
removed!and!cells!were!washed!with!PBS.!15ml!of!RPMI!medium!was!added!
to! each! T75! flask! containing!MSCs! and! cells!were! incubated!MCU@18AC@PE!
Incusafe!CO2!Incubator!(Panasonic,!Leicester,!UK)!for!24!hours!at!37oC,!21%!
O2,!5%!CO2.!70%@80%!confluence!corresponds!to!the!density!where!the!time!
taken! for! the! MSC! population! to! double! is! the! shortest! (i.e.! the! rate! of!
















and! stored! in! a! MDF@U5386S@PE! PRO! ULT! Upright! Freezer! (Panasonic,!
Leicester,!UK)!set!at!@80oC!!until!needed!for!experimentation.!
!
Multiple! freeze/thaw! cycles! of! conditioned! medium! were! avoided! as! this!
could! potentially! damage! proteins/exomes! in! the! samples.! Conditioned!















To! induce! adipogenic! differentiation,! cells! were! cultured! in! adipogenic!
medium.!Complete!MSC!growth!medium!was!used!consisting!of!DMEM!with!
1g/L!glucose,!supplemented!with!1%!NEAA,!1%!L@glut!and!10%!FBS.!This!was!
supplemented!with! 0.5µM!dexamethasone,! 0.5mM! IBMX! ,! 10ug/ml! insulin!
and!100µM!indomethacin.!
!
To! induce! osteogenic! differentiation,! cells! were! cultured! in! osteogenic!
medium.!Complete!MSC!growth!medium!was!used!consisting!of!DMEM!with!
1g/L!glucose,!supplemented!with!1%!NEAA,!1%!L@glut!and!10%!FBS.!This!was!




























































































































hours’! incubation! which! was! standardised! across! experiments! to! avoid!




















220µl! of! working! MTT! solution! was! added! to! each! well! containing! cells.!
Culture!conditions!can!affect! the!ability!of! cells! to! reduce!MTT! reagents! to!
formazan.!Presence!of!compounds!such!as!ascorbic!acid!and!coenzyme!A!can!
interfere!with! the!MTT! assay,!mandating! the! need! for!media! and! cell@free!
controls!for!each!experiment.(228,229)!Thus,!220µl!of!working!MTT!solution!was!


































readings,! we! fitted! exponential! curves! to! the! data! in! Figure! 3.10! and!
determined!that!the!relationship!between!absorbance!and!length!of!time!in!
MTT! is!exponential! in!nature.!Nine! replicate! samples! from!one!experiment!
were! used! for! each! data! point.! Data! is! expressed! as! mean! +/@! standard!
deviation.! Differences! between! experimental! groups! were! evaluated! using!
unpaired!T@tests!assuming!unequal!variance.!A!p!value!of!<0.05!was!deemed!
to!be!significant.!All!data!points!were!compared! to! the!negative! (0!hour! in!
MTT)!control.!
!
To! determine! the! effect! of! conditioned!media! on!BRIN@bd11! cells,! viability!
readings!for!MSC@conditioned!medium!treated!cells!were!normalised!to!their!
respective! non@conditioned! media! controls! for! comparison.! Nine! replicate!










































BRIN@bd11! cells! and! 60,000! per!well! for! TC6! cells.! These! seeding! densities!
resulted! in! 80%! confluence! after! 24! hours’! incubation! for! each! cell! line!
respectively.!This!is!to!prevent!over@confluence!as!described!in!Section!2.3.2.!!!
Nine!wells!were! seeded! for! treatment!with!each!concentration!of! cytokine!
respectively.!Nine!further!wells!were!seeded!as!untreated!control!cells.!Cells!




















220µl! of!working!MTT! solution!was!added! to!each!well! containing! cells.! In!
addition,!220µl!of!working!MTT!solution!was!added!to!9!cell@free!wells!to!act!



























































































































added! to! each! well.! Plate! 1! was! sealed! and! left! to! incubate! at! room!
temperature!for!30!minutes.!
!
Step! 7:! 30!minutes! after! completion! of! Step! 6,! Plate! 1!was! aspirated! and!
washed!four!times!with!wash!buffer.!100µL!of!ABTS!substrate!was!added!to!
















Step! 9:! 30!minutes! after! completion! of! Step! 8,! Plate! 2!was! aspirated! and!
washed!four!times!with!wash!buffer.!100µL!of!ABTS!substrate!was!added!to!





























Data! is! expressed! as! mean! +/@! standard! deviation.! Differences! in!



















was! aspirated! and! the! cells!were!washed!with! PBS.! PBS!was! removed! and!
700µL! of! lysis! buffer! added! to! the!wells.! The! cells!were! left! to! lyse! for! 10!
minutes.! Complete! lysis! of! the! cells!was! visualised!using! a!Olympus!CKX41!

















sterile!extraction! tube! for!membrane!drying!and!centrifuged!at!11.0g! for!1!
minute.!The!filtrate!was!discarded.!!The!membrane!was!transferred!to!a!new!
sterile! cap! vial.! 30μL! RNase@free! water! was! added! and! the! cap! vial! was!
centrifuged!at!11.0g!for!1!minute.!The!sample!within!the!cap!vial!was!kept!for!











































master!mix!was!prepared! consisting!of! 6.25µL!of! 2x! reaction!mix,! 4.5µL!of!
RNase@free!water,!0.25µL!of!Taq!(enzyme)!and!0.25µL!of!desired!forward!and!
























result! with! a! positive! GAPDH! result! indicates! lack! of! expression! of! IL@10!
receptors.! However,! if! the! GAPDH! result! is! also! faulty,! issues! with! the!
experiment!or!RNA!samples!are!likely.!
!















Conversion!to!cDNA! 50! 30!mins! 1!
Initial!denaturation! 94! 2!mins! 1!






















































































































In! this! experiment! isotype! controls! were! used! to! confirm! whether!









of! the! antibodies! to! the! sample! (background! staining).(231)! Apart! from!
differences! in!specificity! to!the!antigen!of! interest,! the! isotype!controls!are!
otherwise! identical! to! their! respective! antigen"specific! antibodies(231)! as!
detailed!in!Table!2.2.!This!allows!comparison!between!the!stains!to!be!made.!!
!
In! addition! to! this,! autofluorescence!of! cells! could! result! in! false! positives.!
Autofluorescence! is! the!natural! emission!of! light! from!biological! structures!
































antibodies! for!binding! to!epitopes! to!which! the!antibodies!are!not!specific.!



































software! (Nikon®,! Miyagi,! Japan).! Images! were! captured! at! 20X! and! 40X!
magnification.!!The!TRITC!filter!on!the!microscope!was!used!for!detection!of!
staining! with! IL10RA! polyclonal! antibody! (A555! conjugate)! and! rabbit! IgG!
isotype! control! (A555! conjugate).! The! FITC! filter!was! used! for! detection!of!
staining! with! IL10RB! polyclonal! antibody! (FITC! conjugate)! and! rabbit! IgG!
isotype!control! (FITC!conjugate).! ! The!DAPI! filter!was!used! for!detection!of!
DAPI!nuclear!stain.!
!
Acquisition! parameters! between! isotype! controls! and! their! corresponding!
antigen"specific! antibodies! were! kept! consistent! to! allow! for! effective!
comparison! between! fluorescence! of! the! isotype! controls! and! the! positive!
stains.! ! IL10RA!polyclonal!antibody!(A555!conjugate)!and!rabbit! IgG! isotype!
control! (A555!conjugate)!were!captured!with!1!second!exposure!and!4.00X!



































isotype! control,! ImageJ! image! analysis! software! was! used! to! quantify! the!
intensity! of! staining! in! the! images.! Quantitative! measurements! are! only!
necessary!if!a!comparison!between!levels!of!protein!expression!between!cells!
is!needed.!This!could!be!to!test!changes!in!protein!expression!after!cells!are!
exposed! to!different!experimental! conditions!or! treatments.!Characterising!
the!presence!of!a!protein!like!the!IL"10!receptor!in!the!case!of!this!experiment!
only! requires! a! qualitative! analysis.! However,! providing! additional!
quantitative!data!demonstrating!the!difference!in!isotype!control!and!positive!
staining!does!improve!the!robustness!of!the!results.!!
Images! of! fields! taken! at! both! x20! and! x40! magnifications! were! used! for!
comparison.!Multiple!intensity!readings!from!at!least!4!areas!of!measurement!
taken!at! random! from!each! field!were!used! for!each!data!point.! To!obtain!
intensity! data! specific! to! antibody! staining,! background! intensity! readings!
were!subtracted!from!intensity!readings!of!stained!cells!in!the!image.!Values!
are! expressed! as!mean!+/"! standard!deviation.! Two"tailed!unpaired! T"tests!
assuming!unequal! variance!were!used! to!determine! the! significance!of! the!









Animal! experiments! described! in! this! section! were! conducted! as! a!









































































In! addition! to! acute! organ! toxicity,! STZ! treatment! in! mice! results! in!





After! 3! months! mice! were! euthanized! via! cervical! dislocation.! Mice! were!
terminally! bled! via! cardiac! puncture! and! serum! used! for! insulin! ELISAs! as!
detailed!in!Section!2.4.2.!DEXA!scans!were!performed!on!mice!using!the!Lunar!
PIXImus! Densitometer! (GE! Medical! Systems,! Slough,! UK)! ! as! described! in!
Section!2.4.3.!The!pancreata!of! the!mice!were! removed!and! the! tail!of! the!
pancreas! was! fixed! in! 4%! paraformaldehyde! in! phosphate! buffered! saline!
(PBS)! for! subsequent! histological! analysis! (Section! 2.4.4).! The! head! of! the!














To! prepare! a! working! conjugate! solution,! conjugate! stock! solution! was!








350µL!of!wash!buffer! per!well.! The!plate!was!blotted!on!a!paper! towel! to!













































































Data! for! each! group! consists! of! 8! measurements,! one! from! each! animal!
respectively.!Data! is!expressed!as!mean!+/"!standard!deviation.!Differences!
















at! 4oC.! As! water! present! in! tissue! is! hydrophobic! tissue! needs! to! be!
dehydrated!before!wax!embedding.!Pancreata!were!processed!using!a!!a!Leica!
TP1020!(Leica!Microsystems,!Nussloch,!Germany)!automated!tissue!processor!
Dehydration! of! samples! was! performed! with! increasing! concentrations! of!
ethanol!solution!(50%,!70%,!80%,!95%,!100%).!Tissue!was!incubated!at!each!














thickness! using! a! ShandonTM! FinesseTM! 325! microtome! (Thermo! Scientific,!









Islet! areas! were! measured! on! ImageJ! image! processing! software.! Areas!
obtained!were!converted! from!pixels! to!µm2.!!At! least!15! islets! taken! from!
multiple!pancreatic!sections!were!used!for!each!data!point.!Data!for!islet!size!



































anergy( through( direct( cell5to5cell( contact,( as( they( lack( the( co5stimulatory(
molecules(required(for(the(activation(of(autoreactive(T5cells.(50,74)(
(
In(addition( to( the( immunoregulatory(effects,( it( could(be(proposed(that( the(
MSC5CM(may(directly(confer(cytoprotection(to(beta(cells(from(inflammatory(
factors( implicated( in( the( pathogenesis( of( type( 1( diabetes.( In( the( diseased(
state,(immune(cells(are(known(to(secrete(factors,(namely(TNFα,(IFNγ(and(IL1β,(
in( the( pro5inflammatory( environment.(117,( 207)( These( factors( are( capable( of(
inducing(apoptosis(of(beta(cells(through(mechanisms(such(as(INO(induction(
and( ER( stress( as( described( in( Chapter( 1.(1185123,140)( The( MSC5CM( has( been(
shown( through( proteomic( studies( to( contain( a( number( of( cytoprotective(













with( islet( cells( from( pancreatic( islets.( They( treated( islet( cells( with( an(
inflammatory( cytokine( cocktail( of( TNFα,( IFNγ( and( IL51β( and( demonstrated(
apoptosis(through(TUNEL(assays.(238)(TUNEL(assays(are(a(method(of(detecting(
























•! Culture( human( bone( marrow( derived( MSCs,( characterise( the( cells(
















































Adipogenic( differentiation( can( be( seen( by( accumulation( of( lipid( vacuoles(
within(cells.(Lipid(vacuoles(accumulated(over(the(three(weeks(of(exposure(to(





the( development( of( cellular( projections( after( a( few( days( of( exposure( to(
osteogenic(medium.(After( three(weeks,( the( extracellular(matrix( stained( an(
intense( red( with( Alizarin( Red( staining( as( depicted( in( Figure( 3.2,( indicating(

















































Chondrogenic( differentiation( medium( resulted( in( the( deposition( of(
proteoglycans(that(exhibited(mild(staining(with(Alcain(Blue(with(some(changes(
in( morphology/lacunae( development( (Figure( 3.3).( However,( cellular(
aggregates( with( intense( blue( staining( expected( with( chondrogenic(















































The( quantity( of( signal( generated( depends( on( several( factors( including( the(
length( of( incubation( in(MTT,( the( concentration( of(MTT( and( the(metabolic(






working( solution( (0.05mg/ml)( and( cell( density( (80%( confluence)( to( be(
determined.(These(experiments(were(also(used(to(determine(whether(there(










































The( relationship( between( absorbance( and( incubation( time( in(MTT( reagent(
was( determined( to( be( exponential( in( nature( (Figure( 3.5).( Data( analysis( is(
described(in(Section(2.3.2.(All(incubation(times(in(MTT(resulted(in(absorbance(
readings( significantly( above( the(negative( control( for( a( cell( density(of( ~80%(




















(with# serum);# C# ># BRIN>bd11# cells# exposed# to# RPMI;# D# ># BRIN>bd11# cells# exposed# to# MSC>CM.#
***p<0.001#
#
3.3.1.2.2!! Effect! of! MSCFCM! on! BRINFbd11! Cell! Viability! (1h! MTT!
incubation)!













nA570)( (Figure( 3.6).( Viability( readings(were( +6.1%( (p<0.1)( greater( for( BRIN5























bd11( cells( cultured( in( MSC5CM+serum( displayed( +14.3%( (p<0.01)( greater(
viability( compared( to( RPMI+serum( (MSC5CM+serum( 1.0 "±" 0.0920( nA570,(
RPMI+serum(1.143"±"0.109( nA570)( (Figure( 3.7).( Viability( readings(were( also(
greater( (+12.6%;( p<0.01)( for( cells( exposed( to(MSC5CM( compared( to( RPMI(



























3.3.1.2.4!! Effect! of! MSCFCM! on! BRINFbd11! Cell! Viability! (3h! MTT!
incubation)!
To(determine(the(effect(of(MSC5CM(on(the(viability(of(BRIN5bd11(cells,(viability(
of( cells( cultured( in(MSC5CM( and( RPMI( for( 24( hours(were( compared.( Cells(
exposed(to(MTT(reagent(for(3(hours(showed(+21.1%((p<0.01)(greater(viability(
readings( for( cells( cultured( in( MSC5CM+serum( compared( to( RPMI+serum(
(MSC5CM+serum(1.0"±"0.191(nA570,(RPMI+serum(1.211+0.0975(nA570)((Figure(
3.8).(Viability(readings(were(also(greater((+5.0%;(p<0.05)(for(cells(treated(with(


































hypothesis( in( vitro,( we( planned( to( expose( BRIN5bd11( cells( to( increasing(
concentrations(of(these(cytokines(individually(as(well(as(a(cytomix(of(all(three(
to(determine(the(effects(on(cellular(viability.(Concentrations(of(cytokines(that(
resulted( in( the(greatest( fall( in(viability(determined( from(these(experiments(
were(determined(to(be(optimal(for(use(in(further(experiments(
(























































(512.2%;( p<0.05)( compared( to( the( control( (cell( control( 1.0( (±"0.102( nA570,(
100ng/ml( TNFα( 0.878"±"0.091( nA570)( (Figure( 3.9)( as( well( as( 1,000ng/ml( (5
21.1%;( p<0.01)( compared( to( the( control( (cell( control( 1.0(±" 0.102( nA570,(




























treated(with( increasing(concentrations((051,000ng/ml)(of( IFNγ( for(24(hours.(
Significant( falls( in( viability( were( seen( for( 10ng/ml( IFNγ( (510.6%;( p<0.05)(
compared(to(the(control((cell(control(1.0(±(0.113(nA570,(10ng/ml(IFNγ(0.894((
±0.045)( (Figure( 3.10).( Significant( falls(were( also( seen( for( 100ng/ml( IFNγ( (5

















































3.3.2.2.4! Effect! of! Increasing! Concentrations! of! Cytomix! on! BRINFbd11!
Cells!
To(determine(the(effect(of(a(cytomix(of(all(three(cytokines,(TNFα,(IFNγ(and(IL5
1β( were(mixed( in( equal( quantities( and( applied( as( a( cytomix( in( increasing(
concentrations( (051,000ng/ml)( to( BRIN5bd11( for( 24( hours.( ( 100ng/ml( of(
cytomix(resulted(in(a(significant(fall( in(viability((59.7%;(p<0.01)(compared(to(
the( control( (cell( control( 1.0(±" 0.054,( 100ng/ml( cytomix( 0.903(± (0.075).(
(Figure(3.12).(1,000ng/ml(cytomix(resulted(in(a(greater(fall(in(viability((515.3%;(
p<0.001)(than(the(control((cell(control(1.0(±"0.054,(1,000ng/ml(cytomix(0.847(





































For(BRIN5bd11( cells( exposed( to( 1,000ng/ml( TNFα,( BRIN5bd11( cells( showed(
significantly(greater(viability((+77.3%;(p<0.001)(for(cells(treated(with(MSC5CM(
compared( to( untreated( cells( (Figure( 3.13).( For( BRIN5bd11( cells( exposed( to(
1,000ng/ml( of( cytomix,( viabilities( were( also( significantly( greater( for( cells(
treated( with( MSC5CM( (+27.4%;( p<0.01)( compared( to( cells( that( were( not(
































the( cytokine.( TC6( cells( appear( more( susceptible( to( TNFα5induced( falls( in(
viability( compared( to( BRIN5bd11( cells.( ( Significant( falls( in( viability( were(
observed(for(concentrations(of(TNFα(of(1ng/ml((516.8%;(p<0.001)(compared(
to( the( control( (cell( control( 1.0(±(0.079( nA570,( 1ng/ml( TNFα( 0.832(±(0.077(
nA570)( (Figure( 3.14).( Treatment( with( 10ng/ml( TNFα( also( resulted( in( a(
significant(fall( in(viability((512.8%;(p<0.01)(compared(to(the(cell(control((cell(
control(1.0(±(0.079(nA570,(10ng/ml(TNFα(0.872(±(0.090(nA570)( (Figure(3.14).(



































(cell( control( 1.0(± (0.112( nA570,( 1ng/ml( IFNγ( ( 0.880(± (0.079( nA570)( (Figure(
3.15).( 10ng/ml( of( IFNγ( resulted( in( a( significant( fall( of( 513.4%( (p<0.05)(
compared( to( the( cell( control( (cell( control( 1.0(±(0.112( nA570,( 10ng/ml( IFNγ((
0.866(±(0.086(nA570)((Figure(3.15).(100ng/ml(resulted(in(a(fall(in(viability(of((5
















the# viability# of# TC6# cells# cultured# in# RPMI# medium# without# serum.# Viability# of# TC6# cells# was#
determined#by#calorimetric#MTT#assays#after#24#hours’#exposure#to#rising#concentrations#of#INFγ.#




















± (0.102( nA570,( 1ng/ml( IL51β( ( 0.811(± (0.082( nA570)( (Figure( 3.16).( 10ng/ml(
resulted( in( a( significant( decrease( (524.2%;( p<0.001)( compared( to( the( cell(
control( (cell( control( 1.0(±(0.102(nA570,( 10ng/ml( IL51β( ( 0.758(±(0.107(nA570)(
(Figure( 3.16).( 100ng/ml( resulted( in( the( greatest( fall( in( viability( (525.7%;(






























of( TC6( cells,( TC6( cells( were( incubated( with( increasing( concentrations( (05














































assays( were( used( to( determine( differences( in( viability.( Optimised(
concentrations(of(cytokines(determined(in(previous(experiments(were(used.(
(




For( TC6( cells( exposed( to( 1,000ng/ml( TNFα,( TC6( cells( showed( significantly(
greater(viability((+12.3%;(p<0.05)(for(cells(treated(with(MSC5CM(compared(to(
untreated(cells((Figure(3.18).(For(TC6(cells(exposed(to(1,000ng/ml(of(cytomix,(





























































limitations( in( the(experimental(method,( the(data(presented( in( this( chapter(
needs(to(be(interpreted(with(caution.(The(MTT(assay(does(not(determine(the(
mechanisms(of(cell(death,((and(only(looks(at(mitochondrial(metabolism(which(
can( be( used( to( quantify( metabolically( active( cells( remaining( in( the( wells.(
Ideally(further(experiments(should(be(performed(to(confirm(that(apoptosis(via(
pro5inflammatory( cytokines( is( indeed( attenuated( by( the( MSC5conditioned(
medium.((
(
In(addition( to( these( findings,(we(have(also(observed(consistently( increased(
viability( readings( of( BRIN5bd11( cells( treated( for( 24( hours( in( MSC5CM(
compared(to(cells(that(are(not(treated(with(MSC5CM(in(the(absence(of(pro5









shown( to(contain( trophic( factors,( including(VEGF,(HGF(and( IGF.(63)( Thus(we(
could(hypothesise( that( in( addition( to( inhibiting( apoptotic(mechanisms,( the(
MSC5CM(may(indeed(promote(cellular(growth(and(division(of(beta(cells.(This(
could(be(another(mechanism(to(account(for(the(increased(islet(size(of(MSC5
CM5treated( mice( in( previous( murine( models( of( diabetes.( Previous( studies(
have( shown( the( capabilities( of( the( MSC( secretome( in( promoting( the(
proliferation(of(a(number(of(cell(types.(A(study(by((Gao(et#al.(demonstrated(
proliferation( of( beta( cells( in( MSC5CM5treated( mice( in( a( STZ( model( of(
diabetes.(243)(They(confirmed(that(MSC5CM(could(upregulate(the(expression(of(
pERK( and( pAKT( in( this( model.( Subsequent( blockage( of( the( pAKT( pathway(
ameliorated( the( proliferative( effect( observed,( indicating( that( the( pathway(
plays(a(crucial(role(in(beta(cell(proliferation.(243)(
(
An( in# vitro( study( conducted( by( Y( Zhou(et# al.( demonstrated( that( umbilical5
derived(MSCs((uMSCs)(secreted(factors(that(improved(the(viability(of(isolated(
rat( islets(separated( from(the(uMSCs(via(a( trans5well(plate.(240)(MTS(viability(
assays( were( used( to( measure( changes( in( viability( in( this( experiment.(










HGF( and( PDGFA.( These( factors(were( shown( to( activate( the( Pi3K( and( pERK(







types.( A( study( by( Li( et# al.( demonstrated( that( MSC5CM( reversed( the(
downregulation( of( MEK( 1/2( and( ERK( 1/2( phosphorylation( via( LPS( in(

















In( the( context( of( the( results( presented( in( this( chapter,( the( potential(
proliferative( effect( of( MSC5CM( on( beta( cells( presents( an( unexpected( and(
exciting( additional( factor.( These( results( could( point( toward( the( MSC5CM(
having(a(direct(trophic(effect(on(beta(cells(in(addition(to(attenuating(cytokine5



















































of( immune( response( through( actions( of( the( MSC5CM( on( immune( cells,(
provision( of( trophic( support( to( beta( cells( through( factors( like( VEGF( that(
promotes( angiogenesis( to( damaged( islets,( as( well( as( the( potential(









The(experiments( in(his(Chapter(were(conducted( to(determine(whether( the(
MSC(secretome(contained( in( the(MSC5CM( is(able( to(ameliorate( the(Type51(
diabetic(state(in#vivo.(The(objectives(of(this(study(are:(((
(
•! Establish( a( murine( model( of( type( 1( diabetes( via( multiple( low( dose(
Intraperitoneal(injections(of(streptozocin((STZ).(




•! Determine( if(MSC5CM( improves( islet(morphology( through(pancreatic(
histology.((
(















































were( performed( on( terminal( plasma( obtained( from( the( mice.( ( Figure( 4.1(
demonstrates(that(treatment(with(STZ(significantly(reduced((523.7%;(p<0.05)(
terminal(plasma( insulin(compared(to(the(non5diabetic(control( (non5diabetic(
control( 0.477(±(0.090ng/ml,( STZ( 0.364"±"0.040ng/ml).(MSC5CM(appears( to(
partially(restore(insulin(secretion(in(STZ5treated(mice.(Mice(treated(with(STZ(
and(MSC5CM(had(greater((+24.4%;(p(=(0.08)(terminal(plasma(insulin(compared(
































mice( (55.4%;( p<0.001)( and(MSC5CM5treated( diabetic(mice( (56.4%;( p<0.001)(
compared(to(the(non5diabetic(controls((non5diabetic(control(27.05(±(0.926g,(


































































This( is( thought( to( result( from( an( inability( of( diabetic( mice( to( metabolise(
carbohydrate( food( stores,( leading( to( a( shift( to( fatty( acid( metabolism( and(
subsequent(loss(of(body(fat(as(depicted(in(the(DEXA(scans(we(conducted.(248)((
Treatment(with(MSC5CM(appears( to(have( improved( islet( function(and( islet(
morphology(as(determined(by(serum(ELISAs(and(histological(analysis(at(the(





dysfunction.(117,( 123,143,144,146)( Although( the( beta( cell(mass( in( the( STZ( treated(
mice(may(be(maintained(by(the(trophic(and(cytoprotective(effects(of(the(MSC5
CM,(the(beta(cells(may(be(dysfunctional(and(unable(to(appropriately(secrete(
insulin( in( response( to( changes( in( blood( glucose.( Thus( a( shift( to( fatty( acid(









(IPGTT)( could( provide( insight( in( to( the( functionality( of( beta( cells( in( mice(
treated( with( streptozocin( and( whether( MSC5CM( could( prevent( beta( cell(
dysfunction(and(improve(insulin(responsiveness.(STZ(is(also(known(to(cause(
hepatotoxicity(and(nephrotoxicity(which(could(result(in(stress(and(subsequent(
weight( loss.(237)(This(may(account( for( some(of( the(weight( loss( seen( in(both(
groups(of(STZ(treated(mice.((
(
There( are( significant( limitations( to( the( experimental( method( used( in( this(
chapter.(The(study(looked(at(a(snapshot(of(the(insulin(profile,(islet(histology(
and(body(fat(content(at(the(time(of(culling.(This(does(not(allow(for(a(trend(to(
be( determined( for( glycaemic( control( and( body( habitus.( Ideally,( the(
experiment(should(be(conducted(to(allow(for(periodic(monitoring(of(the(blood(
glucose( and( body( weight( as( well( as( serum( insulin( over( the( course( of( the(
experiment.( The( experiment( was( also( performed( with( 8( animals( in( each(
group,(which(presents(a(relatively(small(sample(size.(Ideally,(a(larger(sample(












secretion( and( islet( histology( of( diabetic(mice( in( this( experiment,( although(


































have! shown! promising! results.! A! number! of! studies! including! a! study! by!
Voltarelli! et! al.! have! shown! improved! biochemical! markers! for! patients!















MTT! assays.! We! have! also! demonstrated! improved! islet! function! in! rats!
treated! with! MSC2CM! in! an! in! vivo! streptozocin! model! of! diabetes.! The!
components! of! the! secretome! that! confer! these! therapeutic! properties!
remain! to! be! fully! characterised,! and! this! is! an! area! that! is! being! studied!

























in! tissues! such!as!epithelial! cells!of! the! lung!and! small! intestine.(250,251)! The!







•! Characterise! the! presence! of! the! IL210! receptor! on! beta! cell! lines!
through!Electrophoresis!












































The! concentration! of! IL210! in!MSC2CM!was! determined! to! be! 3,529!±"195!
pg/ml.!The!concentration!of!IL210!fell!significantly!(254.4%;!p<0.001)!after!one!
transfer! (T0! 3,529 "±" 195pg/ml,! T1! 1,610 "±" 506pg/ml).! After! the! second!
transfer,!the!concentration!was!determined!to!have!fallen!significantly!again!
(288.1%;!p<0.001)!as! compared! to!T1! (T1!1,610"±"195pg/ml,!T2!192"±"655)!














Figure'5.1' :'Serial'ELISAs'for'detection'of' IL:10'concentrations' in'MSC:conditioned'RPMI'medium'
(MSC:CM).'T0'represents'concentrations'of'IL:10'in'MSC:CM'(Plate'1).'T1'shows'concentration'of'IL:

















































































be! a! result! of! several! causes,! including! RNA! contamination! of! the! original!
BRIN2bd11!RNA!sample!and!non2specific!binding!of!the!primers.!The!negative!
controls!showed!no!bands,!indicating!that!RNA!contamination!did!not!occur!




































































































































































































































Figure'5.3' :'Electrophoresis'of'BRIN:bd11'cells' (Experiment'2).'1' :'DNA' ladder;'2' :' IL10RA'(BRIN:
bd11);'3':'IL10RA'(negative'control);'4':'IL10RB'(BRIN:bd11);'5':'IL10RB'(negative'control);'6':'GAPDH'
(BRIN:bd11);'7':'GAPDH'(negative'control);'8':'DNA'ladder;'9':'IL10RA'(Jurkat);'10':'IL10RA'(negative'












A! new! batch! of! RNA! was! extracted! from! BRIN2bd11! cells.! RT2PCR! and!
electrophoresis!were!subsequently!performed.!However,! in!this!experiment!
the!Jurkat!positive!control!was!omitted!as!primers!designed!to!be!specific!to!
the!gene! template!of! rattus!norvegecus!will!not!work! for!a!human!derived!
Jurkat! T2cell! line.!New!primers!were! designed!using! the! gene! template! for!
rattus' norvegicus! and! custom! oligos! were! ordered! from! Thermo! Fisher!
Scientific.!These!primers!are!detailed!in!Table!5.3.!
!
The! final! product! size! for! IL10RA,! IL10RB! and! GAPDH! was! as! expected! as!
illustrated! in! Figure! 5.4b.! ! This! demonstrates! that! species2specific! primers!
should!be!designed!for!RT2PCR.!There!was!however!laddering!of!the!bands!as!
shown!in!Figure!5.4a.!This!could!again!be!due!to!non2specific!binding!of!the!
primers! or! RNA! contamination! of! the! RNA! sample.! The! experiment! was!














in! Figure! 5.6b.! This! experiment! demonstrates! that! closely! matching! the!
annealing!temperature!of!the!thermal!cycler!to!the!melting!temperature!of!





showed! positive! results! for! IL10RA! as! depicted! in! Lane! 2! of! Figure! 5.6a!
(expected!bp!313).!!Positive!results!were!shown!for!IL10RB!as!depicted!in!Lane!
4!of!Figure!5.6a!(expected!bp!483).!Positive!results!were!shown!for!GAPDH!as!


















































































































































for! IL10RA!as!depicted! in!Lane!2!of!Figure!5.7a! (expected!bp!360).!Positive!
results!were!shown!for!IL10RB!as!depicted!in!Lane!4!of!Figure!5.7a!(expected!
bp!618).!Positive!results!were!seen!for!GAPDH!as!depicted!in!Lane!6!of!Figure!





















































































































































































































































































conditions! detailed! in! Section! 2.2.3,! fluorescent! conjugated! antibodies!
specific!to!the!IL10RA!and!IL10RB!components!of!the!receptor!were!utilised!to!
allow!visualisation!of!receptor!expression.!Staining!with!antibodies!specific!to!
IL10RA! resulted! in! a! fluorescent! intensity! visibly! greater! than! that! of! the!
isotype!control!(Figure!5.9).!No!autofluorescence!was!seen!for!BRIN2bd11!cells!
stained! with! DAPI! (Figure! 5.9).! Quantification! of! fluorescence! intensity!


















Figure'5.9' :' Immunofluorescence' images'demonstrating'expression'of' IL10RA'receptors'by'BRIN:
bd11'cells.'IL10RA:specific'antibodies'resulted'in'a'significantly'greater'fluorescence'intensity'than'








































































by'BRIN:bd11'cells.' Fluorescence' intensities'of'antigen:specific'antibodies'are' compared' to' their'
respective'isotype'controls'for'fields'taken'at'x20'magnification.'Isotype'intensities'are'normalised'


















detailed! in! Section! 2.2.3,! fluorescent! conjugated! antibodies! specific! to! the!
IL10RA! and! IL10RB! components! of! the! receptor! were! utilised! to! allow!
visualisation! of! receptor! expression.! Staining! with! antibodies! specific! to!
IL10RA! resulted! in! a! fluorescent! intensity! visibly! greater! than! that! of! the!
isotype!control!(Figure!5.12).!No!autofluorescence!was!seen!for!MSCS!stained!
with! DAPI! (Figure! 5.12).! Quantification! of! fluorescence! intensity!





































































































To! determine! whether! TC6! cells! express! the! IL210! receptor! in! culture!
conditions! detailed! in! Section! 2.2.3,! fluorescent! conjugated! antibodies!
specific!to!the!IL10RA!and!IL10RB!components!of!the!receptor!were!utilised!to!
allow!visualisation!of!receptor!expression.!Staining!with!antibodies!specific!to!
IL10RA! resulted! in! a! fluorescent! intensity! visibly! greater! than! that! of! the!
isotype! control! (Figure! 5.15).! No! autofluorescence! was! seen! for! TC6! cells!
stained! with! DAPI! (Figure! 5.15).! Quantification! of! fluorescence! intensity!
demonstrated! a! significantly! greater! (+56.3%;! p<0.001)! intensity! of! the!
positive!stain!compared!to!the!control!(Figure!5.17).!Staining!with!antibodies!














Figure'5.15' :' Immunofluorescence' images'demonstrating' expression'of' IL10RA' receptors' by' TC6'
cells.' IL10RA:specific'antibodies'resulted' in'a'significantly'greater' fluorescence' intensity'than'the'
















































































a! complex!cocktail!of! soluble! factors! that!are! secreted!by! the!MSCs.!These!
include!angiogenic!factors!(e.g.!VEGF,!angiogenin),!Growth!and!trophic!factors!
(e.g.! BDNF,! EGF,! PIGF),! chemokines! (e.g.! CCL1,! CXCL2),! anti2inflammatory!
cytokines!(e.g.!IL210,!IL213)!and!haematopoietic!cytokines,!among!others.(63)!
!






assays,!and!as!described! in!Chapter!1,! IL210! is!a!cytokine! that!acts! through!











as! an! immunosuppressant! and! attenuating! the! autoimmune! response.(200)!
Administration!of! IL210! to!diabetic!mice!has!shown!mixed!results.!Systemic!







cytoprotection! to! beta! cells! in! the! context! of! type! 1! diabetes! has! to! my!

















the! nucleus.! As! alluded! to! earlier,! IL210! may! be! able! to! attenuate! pro2
inflammatory!cytokine2driven!apoptosis!in!beta!cells!through!the!blockage!of!
NF2κB!signal!transduction.!Further!study!is!however!required!to!determine!the!


























on! in# vitro! and! in# vivo#models! of! diabetes.! An! Exploration! of! the! current!




to! progressive! depletion! of! the! beta! cell! mass! and! eventual! clinical!
manifestation! of! the! disease.(113G117)! Finding! a! way! to! inhibit! biochemical!
pathways!activated!by!these!cytokines!may!present!the!possibility!of!slowing!
or! even! halting! the! progression! of! the! disease.! Studying! the! stem! cell!
secretomes! ability! to! ameliorate! beta! cell! destruction! could! provide! an!
avenue! to! unravel! the! biochemical! pathways! involved! in! conferring! its!
















have! indicated!a!possible! synergistic! effect!of! these! cytokines! in!mediating!
beta!cell!apoptosis.!The!in!vitro!study!by!Yeung!et#al.#demonstrated!decreased!
apoptosis!and!improved!survival!of!islet!cells!exposed!to!a!cytomix!of!these!
three! proGinflammatory! cytokines! when! coGcultured! in! the! same!
compartment!with!MSCs.(238)!We!demonstrated!via!colorimetric!MTT!assays!





dose! streptozocin! in# vivo! model! of! diabetes.! Our! results! demonstrated!
improved! islet! function! and! restoration! of! insulin! secretion! in! MSCGCMG
treated!mice.!Previous!studies!have!demonstrated!the!ability!of!the!MSCGCM!
to! repair! islets! from!diabetic!mice! through! trophic! actions! of!MSCs,!which!









conferred! the! improved! insulin! metabolism! seen! in! our! experiment.!
Immunoregulation! and! increased! proliferation! of! beta! cells! are! potential!
mechanisms!cited!in!previous!studies.!(74,238,240)!
!
The! mechanisms! whereby! the! MSCGCM! protects! cytokineGmediated!
reductions!in!beta!cell!viability!seen!in!our!in#vitro!experiments!remain!to!be!
elucidated.! The! NFGκB! and! APG1! pathways! have! been! implicated! in! the!
pathogenesis! of! the! disease.(118G120,158G161,187)! ! Indeed,! the! use! of! NFGκB!
inhibitors! has! been! shown! to! significantly! reduce! ILG1β+IFNγGinduced!
apoptosis!of!beta!cells.(120)!Furthermore,!Blockage!of!NFGκB!in!the!multipleGlow!


















inhibiting! the! immune! response! through! the!blockage!of!NFGκB! in! immune!
cells! is! well! documented.(174,188)! Chapter! 5! of! the! thesis! demonstrated! the!
presence!of!ILG10!receptors!on!beta!cell!lines,!which!indicates!that!ILG10!could!





Type! 1! diabetes! is! a! chronic! condition! that! requires! lifelong! treatment! to!
prevent! complications.! Complications! associated! with! diabetes! are! still! a!
major! cause! of! morbidity! and! mortality! for! diabetics! worldwide.! Finding!
treatments! that! could! stop! the! progression! of! the! disease! in! susceptible!















depletion! of! islet! mass! and! onset! of! clinical! diabetes! occurs! may! be! a!
possibility.!
!
In! this! thesis,! we! have! demonstrated! that! the! mesenchymal! stem! cell!
secretome!appears!to!have!therapeutic!properties!on!beta!cells!in!both!in!vitro!
and! in! vivo!models.! Our! study! has! however! only! scratched! the! surface! in!
developing! an! understanding! of! the! therapeutic! potential! of! the! MSC!
secretome! in! the! treatment! of! diabetes.! The!MSC! secretome! represents! a!












Over! the!course!of! this!nine!month!project,! I!have!explored!the!viability!of!
MSCGCM!as!a!potential!option!for!the!treatment!of!type!1!diabetes!and!have!
started!some!of!the!characterisation!experiments!for!ILG10!signalling!to!begin!
looking!at! the!biochemical!pathways! that!may!confer! the!beneficial!effects!


















































Future! studies! could! involve! unravelling! the! signal! transduction! pathways!
which! the! soluble! factors! in! the!MSCGCM! act! upon! in! beta! cells.!We!were!
particularly!interested!in!the!potential!of!ILG10!to!confer!cytoprotective!effects!
directly! to! beta! cells! and! its! potential! ability! to! block! NFGκB! signal!
transduction.!Thus,!further!study!into!the!activity!of!NFGκB!in!cells!challenged!
with!proGinflammatory!cytokines!could!be!undertaken!comparing!cells!treated!
with! MSCGCM! and! untreated! controls.! This! would! allow! us! to! determine!
whether!MSCGCM!blocks!NFGκB!activation.!!
!
The! in# vivo! experiment! in! this! thesis! presented! a! number! of! limitations! as!
discussed!in!Chapter!4.!Further!study!could!involve!conducting!the!experiment!













components! of! the! MSC! secretome! that! confer! its! therapeutic! benefit.!
Another! limitation!highlighted! in! chapter!4! is! that! the! functionality!of!beta!
cells! were! not! tested! in! this! thesis.! Measuring! insulin! secretion! through!
glucose!challenges!could!be!used!to!determine!whether!the!MSC!secretome!
can!ameliorate!beta!cell!dysfunction!in!addition!to!preserving!beta!cell!mass.!
!
Recent!discoveries!have!shown!that!in!addition!to!soluble!factors,!exomes!play!
an!important!role!in!modifying!the!disease!state.!Being!capable!of!mediating!
horizontal!transfer!of!genetic!material!between!MSCs!and!target!cells,! they!
could!play!a!key!role!in!mediating!the!protective!effects!seen!in!our!model!of!
type!1!diabetes.!Characterising!the!exomes!released!by!MSCs!and!the!genes!
they!transfer!to!beta!cells!and!immune!cells!implicated!in!the!pathogenesis!of!
diabetes!is!another!avenue!that!could!be!explored!in!the!future.!!
!
The!use!of!stem!cell!products!for!the!treatment!of!diseases!is!an!exciting!field!
that!shows!promise!as!a!potential!therapeutic!option! in!the!future.!Further!
research!in!this!field!may!result!in!treatments!that!could!halt!and!reverse!the!
pathogenesis!of!diseases!like!type!1!diabetes.!!
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